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Definition  
• Systemic connective tissue diseases (systemic 
autoimmune diseases, collagen diseases, collagen 
vascular diseases , SCTD) refer  to a group of chronic 
autoimmune inflammatory disorders involving the 
protein-rich connective tissue that supports organs 
and other parts of the body, first of all the joints, 
muscles, skin, and other organs and organ systems, 
including the eyes, heart, lungs, kidneys, 
gastrointestinal tract, and blood vessels. 
• There are more than 200 disorders that affect the 
connective tissue.  
http://www.webmd.com/a-to-z-guides/connective-tissue-disease 
Classification  
 
Heritable SCTD 
• Marfan syndrome   
• Peyronie's disease   
• Ehlers-Danlos syndrome    
•  Osteogenesis imperfecta   
• Stickler syndrome   
• Alport syndrome   
• Congenital contractural arachnodactyly   
• Loeys–Dietz syndrome   https://en.wikipedia.org/wiki/Connective_tissue_disease 
Classification 
Acquired SCTD 
• Systemic lupus erythematosus (SLE) 
• Rheumatoid arthritis   
• Sjögren syndrome   
• Psoriatic arthritis 
• Dermatomyositis (DM) 
• Polymyositis (PM) 
• Anti-synthetase syndrome  
• Mixed connective tissue disease  
• Scurvy   https://en.wikipedia.org/wiki/Connective_tissue_disease 
Mechanisms   
(The Connective Tissues Abnormalities) 1  
http://rheumatology.oxfordjournals.org/content/45/suppl_3/iii1.full http://emedicine.medscape.com/article/335815-overview#a4 
• SCTD have the connective tissues of the body as a 
target of chronic autoimmune progressive 
inflammation.  
• The connective tissues abnormalities include 
impaired angiogenesis as well as immunological 
alterations, e.g. B-lymphocytes and T-lymphocytes 
activation , self-antigens apoptotic modification and 
immune response against them, widespread 
lymphocytic and plasmacytic infiltration, activation 
of Toll-like receptors, etc. with abundant fibrinoid 
deposits.   
Mechanisms   
(The Connective Tissues Abnormalities) 2 
http://rheumatology.oxfordjournals.org/content/45/suppl_3/iii1.full http://emedicine.medscape.com/article/335815-overview#a4 
• SCTD characterized by varying tissue distribution 
with different pattern of organ involvement. 
Mechanisms   
(Body Systems Affected by SCTD)  
http://www.lifeextension.com/~/media/lef/images/magazine/mag2014/images/mar2014_smad_05.ashx 
Mechanisms    
(Different Diseases associated with Specific 
Autoantibodies) 
Disease 
• Systemic Lupus 
Erythematosus  
• Rheumatoid Arthritis  
• Sjögren Syndrome Systemic 
Sclerosis 
• Polymyositis/Dermatomyosi
tis Mixed Connective Tissue 
Disease  
• Wegener’s Granulomatosus 
Autoantibody 
• Anti-dsDNA, Anti-SM  
• RF, Anti-RA33 
• Anti-Ro(SS-A),Anti-
La(SS-B)  
• Anti-Scl-70, Anti-
centromere  
• Anti-Jo-1  
• Anti-U1-RNP 
• c-ANCA 
 
rheumatology.oxfordjournals.org/content/45/suppl_3/iii1.full 
Diagnosis 
(Connective Tissue Disease Cascade (CTDC)) 
  
https://en.wikipe http://www.mayomedicallaboratories.com/it-mmfiles/Connective_Tissue_Disease_Cascade__CTDC_.pdf dia.org/wiki/Rheumatoid_arthritis#Signs_and_symptoms 
Marfan syndrome 
(Definition) 1 
• Marfan syndrome (MFS) is a spectrum of 
disorders caused by a heritable genetic 
defect of connective tissue that has an 
autosomal dominant mode of 
transmission. 
• The defect itself has been isolated to 
the FBN1gene on chromosome 15, which 
codes for the connective tissue protein 
fibrillin.  
https://stottilien.files.wordpress.com/2014/01/echnaton.png https://en.wikipedia.org/wiki/Marfan_syndrome rheumatology.oxfordjournals.org/content/45/suppl_3/iii1.full 
Pharaoh 
Akhenaton 
Marfan syndrome 
(Definition) 2 
• Abnormalities in fibrillin cause a myriad of 
distinct clinical problems, of which the 
musculoskeletal, cardiac, and ocular 
system. 
https://stottilien.files.wordpress.com/2014/01/echnaton.png https://en.wikipedia.org/wiki/Marfan_syndrome rheumatology.oxfordjournals.org/content/45/suppl_3/iii1.full 
Pharaoh 
Akhenaton 
Marfan syndrome 
(External Signs) 
www.somospacientes.com/wp-content/uploads/2013/04/S%C3%ADndrome-de-Marfan.jpg mayoclinic.org/diseases-conditions/marfan-syndrome/symptoms-causes/dxc-20195415 
a)the Steinberg sign  
b)the Walker-Murdoch sign 
Marfan syndrome 
(Pectus Carinatum Deformity) 
http://www.londonorthotics.co.uk/media/22949/pectuse-cs1-before_boxpromo.jpg 
Pectus carinatum also called pigeon 
chest, is adeformity of the chest 
characterized by a protrusion of the 
sternum and ribs. 
Marfan syndrome 
(Dural Ectasia) 
http://www.neurology.org/content/71/17/1378/F1.expansion.html 
T1- and T2-weighted sagittal MR images of the 
lumbar spine reveal enlargement of the thecal sac 
(yellow arrow) with mild scalloping of the lumbar 
vertebral bodies and marked focal thinning of the 
sacrum (white arrow). An enlarged flow void anterior 
to the spine (red arrow) is related to dilation of the 
descending aorta 
Marfan syndrome 
(Echocardiography)1 
http://circ.ahajournals.org/content/117/21/2802#T1 
A) Two-dimensional echo image in 
the parasternal long axis 
demonstrates dilation of the 
aortic root in a MFS patient.  
B) Color Doppler echo shows mild 
regurgitation through an 
otherwise normal aortic valve, 
which results from the dilatation 
of the root.   
Marfan syndrome 
(Echocardiography)2 
http://circ.ahajournals.org/content/117/21/2802#T1 
A) MFS patient with moderate 
mitral valve prolapse, 
demonstrated in 2-dimensional 
echo images.  
B) Classic M-mode demonstration 
of prolapse of the posterior 
mitral valve leaflet (arrow). 
Marfan syndrome 
(Computed tomography) 
http://circ.ahajournals.org/content/117/21/2802#T1 
• A) Volume-rendered computed tomographic 
angiography image demonstrates the dilatation of 
the proximal aortic root and ascending aorta.  
• B and C) Computed tomographic imaging 
demonstrates evidence of acute type A dissection 
(arrows). 
Marfan syndrome 
(Ectopia Lentis) 
http://www.aapos.org/terms/conditions/68 
• Ectopia lentis is a shift in the location of 
the lens inside the eye.  
• The lens moves from its centered location 
in the eye so that the person is not 
looking through the center of their lens.   
• This dislocation is caused by weakness in 
the connective tissue that holds the lens 
in place (zonules).  
Retroil- 
lumina-
tion 
Marfan syndrome 
(Diagnostic Criteria) 1 
• The diagnosis of MFS relies on a set of defined 
clinical criteria (the Ghent nosology) revised in 
2010.   
• The criteria puts more weight on the cardiovascular 
manifestations of the disorder.  
• Aortic root aneurysm and ectopia lentis (dislocated 
lenses) are now cardinal features. 
• In the absence of any family history, the presence of 
these two features is sufficient for the unequivocal 
diagnosis of Marfan syndrome.  
 
http://jmg.bmj.com/content/47/7/476.abstract 
Marfan syndrome 
(Diagnostic Criteria) 2 
• In the absence of one of these two cardinal 
features, the presence of an FBN1 mutation of 
positive systemic score is required.  
 
http://jmg.bmj.com/content/47/7/476.abstract 
Marfan syndrome 
(Diagnostic Criteria: In the Absence of Family History) 
• Aortic Root Dilatation Z score ≥ 2 AND Ectopia Lentis 
= Marfan syndrome   
• Aortic Root Dilatation Z score ≥ 2 AND FBN1 = 
Marfan syndrome   
• Aortic Root Dilatation Z score ≥ 2 AND Systemic 
Score ≥ 7pts = Marfan   
• Ectopia lentis AND FBN1 with known Aortic Root 
Dilatation = Marfan syndrome   
http://jmg.bmj.com/content/47/7/476.abstract 
Marfan syndrome 
(Diagnostic Criteria: In the Presence of Family History) 
• Ectopia lentis AND Family History of Marfan 
syndrome (as defined above) = Marfan syndrome   
• A systemic score ≥ 7 points AND Family History of 
Marfan syndrome (as defined above) = Marfan   
• Aortic Root Dilatation Z score ≥ 2 above 20 yrs. old, 
≥ 3 below 20 yrs. old) + Family History of Marfan 
syndrome (as defined above) = Marfan syndrome   
http://jmg.bmj.com/content/47/7/476.abstract 
Marfan syndrome 
(Diagnostic Criteria: Points for Systemic Score) 1 
• Wrist AND thumb sign = 3 (wrist OR thumb sign = 1) 
• Pectus carinatum deformity = 2 (pectus excavatum 
or chest asymmetry = 1) 
• Hindfoot deformity = 2 (plain pes planus = 1) 
• Dural ectasia = 2 
• Protrusio acetabuli = 2 
• pneumothorax = 2  
• Reduced upper segment/lower segment ratio AND 
increased arm/height AND no severe scoliosis = 1 
 
http://jmg.bmj.com/content/47/7/476.abstract 
Marfan syndrome 
(Diagnostic Criteria: Points for Systemic Score) 2 
http://jmg.bmj.com/content/47/7/476.abstract 
• Scoliosis or thoracolumbar kyphosis = 1 
• Reduced elbow extension = 1 
• Facial features (3/5) = 1 
(dolichocephaly, enophthalmos, 
downslanting palpebral fissures, 
malar hypoplasia, retrognathia) 
• Skin striae (stretch marks) = 1 
• Myopia > 3 diopters = 1 
• Mitral valve prolapse 1⁄4 1 
Marfan syndrome 
(Physical activity) 1 
• Probably permissible activities: bowling, golf, 
skating (but not ice hockey), snorkeling, brisk 
walking, treadmill, stationary biking, modest hiking, 
and doubles tennis. 
• Intermediate risk: basketball (both full and half-
court), racquetball, squash, running (sprinting and 
jogging), skiing (downhill and cross-country), soccer, 
singles tennis, touch (flag) football, baseball, 
softball, biking, lap swimming, motorcycling, and 
horseback riding.  https://en.wikipedia.org/wiki/Marfan_syndrome#Management 
Marfan syndrome 
(Physical activity) 2 
• High risk: body building, weightlifting (non-free and 
free weights), ice hockey, rock climbing, 
windsurfing, surfing, and scuba diving. 
https://en.wikipedia.org/wiki/Marfan_syndrome#Management 
Marfan syndrome 
(Management) 1 
• Although future therapy directed at the fibrillin-1 
gene or the TGF-β axis may ultimately prove most 
effective at preventing the aortic complications of 
MFS , β-blocker therapy currently remains the 
“standard of care”  or if not tolerated calcium 
channel blockers, angiotensin converting enzyme  
• (ACE) inhibitors or  angiotensin II receptor 
antagonists (ARBs) can be use.  
 
 http://emedicine.medscape.com/article/946315-overview http://circ.ahajournals.org/content/117/21/2802#T1 
Marfan syndrome 
(Management) 2 
• Management of type A acute dissection of the 
aorta is a surgical emergency.  
• The initial management patients with type B acute 
dissection of the aorta can employ standard 
medical approaches. 
• Surgical repair of the severely regurgitant mitral 
valve is possible.  
 
 http://emedicine.medscape.com/article/946315-overview http://circ.ahajournals.org/content/117/21/2802#T1 
US MLE TEST 
A 16-year-old male presents to an ophthalmologist as a new patient 
with a complaint of blurry vision. He reports that over the past several 
months he has had increasing difficulty seeing the board from the back 
of the classroom at school. The patient is otherwise doing well in school 
and enjoys playing basketball. His past medical history is otherwise 
significant for scoliosis which is managed by an orthopedic surgeon. His 
family history is significant for a mother with type II diabetes mellitus, 
and a father who underwent aortic valve replacement last year. On 
physical exam, the patient is tall for his age and has long arms. He has 
20 degrees of thoracic scoliosis, which is stable from previous exams. On 
slit-lamp examination, the patient is found to have bilateral upward lens 
subluxation and is prescribed corrective lenses. Which of the following 
is the most likely etiology of this patient’s presentation?   
1.  Defective metabolism of methionine, 2.  Extra copy of sex 
chromosome, 3.  Mutation of gene on chromosome 15, 4.  Mutation of 
COL5A1 or COL5A2, 5.  Mutation of RET proto-oncogene.  
 
https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 3.  This patient presents with tall stature, upward 
lens subluxation, and a family history of aortic valve disease, which 
suggests a diagnosis of Marfan's syndrome. Marfan's syndrome is 
caused by an autosomal dominant mutation in the fibrillin-1 gene on 
chromosome 15. 
Incorrect Answers: 
1: Defective metabolism of methionine describes homocystinuria, an 
autosomal recessive deficiency of cystathionine synthase, 2: Extra copy 
of a sex chromosome describes Klinefelter syndrome (47,XXY), 4: 
Mutation of COL5A1 or COL5A2 leads to Ehlers-Danlos syndrome, a 
collagen disorder that commonly presents with joint hypermobility, skin 
hyperextensibility, and skin fragility with easy bruising, 5: Mutation of 
RET proto-oncogene describes multiple endocrine neoplasia type 2B 
(MEN2B).   
https://www.mommd.com/usmle1to10.shtml 
Marfan syndrome 
(Management) 3 
• In end-stage heart failure, orthotopic 
transplantation is an effective approach. 
• Any spinal surgery should only follow detailed 
imaging and careful surgical planning. 
 
 http://emedicine.medscape.com/article/946315-overview http://circ.ahajournals.org/content/117/21/2802#T1 
Systemic Lupus Erythematosus 
(Definition) 
• Systemic lupus erythematosus (SLE), also known 
simply as lupus,  is a chronic autoimmune 
inflammatory disease that has protean 
manifestations and follows a relapsing and 
remitting course.   
• Common symptoms include painful and swollen 
joints, fever, chest pain, hair loss, mouth 
ulcers, swollen lymph nodes, feeling tired, and a 
red rash which is most commonly on the face.  
• More than 90% of cases of SLE occur in women, 
frequently starting at childbearing age.  
http://emedicine.medscape.com/article/332244-overview https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus 
Systemic Lupus Erythematosus 
(Manifestations) 1 
• Constitutional (e.g., fatigue, fever, arthralgia, 
weight changes). 
• Musculoskeletal (e.g., arthralgia, arthropathy, 
myalgia, frank arthritis, avascular necrosis). 
• Dermatologic (e.g., malar rash, photosensitivity, 
discoid lupus). 
• Renal (e.g., acute or chronic renal failure, acute 
nephritic disease).  
http://emedicine.medscape.com/article/332244-overview#showall 
Systemic Lupus Erythematosus 
(Manifestations) 2 
• Neuropsychiatric (e.g., seizure, psychosis). 
• Pulmonary (e.g., pleurisy, pleural effusion, 
pneumonitis, pulmonary hypertension, interstitial 
lung disease). 
• Gastrointestinal (e.g., nausea, dyspepsia, 
abdominal pain). 
• Cardiac (e.g., pericarditis, myocarditis). 
• Hematologic (e.g., cytopenias such as leukopenia, 
lymphopenia, anemia, or thrombocytopenia). 
http://emedicine.medscape.com/article/332244-overview#showall 
Systemic Lupus Erythematosus 
(Most Common Symptoms) 
https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus 
Systemic Lupus Erythematosus 
(Malar Rash) 
The first criterion of SLE is a malar 
rash, also called butterfly rash, 
characterized by an erythema over 
the cheeks and nasal bridge (but 
sparing the nasolabial folds).  
It lasts from days to weeks and is 
occasionally painful or pruritic. 
http://2.bp.blogspot.com/-KB_jTj2IeVQ/U_6ePJ0Ll6I/AAAAAAAAAHU/t82ZVnCnxgQ/s1600/malar%20rash%20image.JPG 
Systemic Lupus Erythematosus 
(Photosensivity) 
Photosensitive SLE rashes typically occur on the face 
or extremities, which are sun-exposed regions. 
Although the interphalangeal spaces are affected, the 
metacarpophalangeal (MCP) and proximal 
interphalangeal (PIP) and distal interphalangeal (DIP) 
joints are spared.  
http://emedicine.medscape.com/article/332244-overview 
Systemic Lupus Erythematosus 
(Discoid Rash) 1 
• Discoid rashes are usually slightly elevated red or 
pink areas that form flakes or a crust on the 
surface of the skin and are rarely found below 
the chin, occurring most often on the scalp, and 
outer ear, and almost never on the legs.     
http://diseasesdefinition.com/wp-content/uploads/2014/12/Discoid-Lupus-Erythematosus.jpg 
Systemic Lupus Erythematosus 
(Discoid Rash) 2 
• Rashes may be itchy and get larger, spreading 
outward and then leaving a central scar.  In 
individuals with darker complexions, the central 
area can become de-pigmented; in all individuals 
the outer red area may become hyper-
pigmented. 
http://diseasesdefinition.com/wp-content/uploads/2014/12/Discoid-Lupus-Erythematosus.jpg 
Systemic Lupus Erythematosus 
(Oral Ulcers) 
A 30-year-old male with systemic lupus 
erythematosus presented a palatal ulcer typical for 
lupus. 
http://www.tannlegetidende.no/image/2015/F15-02-008.jpg 
Systemic Lupus Erythematosus 
(Serositis) 
Serositis refers to inflammation of the serous tissues 
of the body, the tissues lining the lungs (pleura), heart 
(pericardium), and the inner lining of the abdomen 
(peritoneum) and organs within. 
http://journal.publications.chestnet.org/article.aspx?articleid=1211826 
Systemic Lupus Erythematosus 
(Renal Disorder ) 
Glomerular disease with SLE is common, and lupus 
nephritis can have many morphologic manifestations 
as seen on renal biopsy. 
http://library.med.utah.edu/WebPath/RENAHTML/RENAL120.html 
Systemic Lupus Erythematosus 
(Laboratory Tests) 1 
• Antinuclear antibody (ANA) testing and anti-
extractable nuclear antigen (anti-ENA) form the 
mainstay of serologic testing for SLE, although ANA 
screening yields positive results in many connective 
tissue disorders and other autoimmune diseases, 
and may occur in normal individuals.   
https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus#Diagnosis 
Systemic Lupus Erythematosus 
(Laboratory Tests) 2 
• Subtypes of antinuclear antibodies include anti-
Smith and anti-double stranded DNA (dsDNA) 
antibodies (which are linked to SLE) and anti-
histone antibodies (which are linked to drug-
induced lupus); anti-dsDNA antibodies are highly 
specific for SLE. 
•  Other tests routinely performed in suspected SLE 
are complement system levels (low levels suggest 
consumption by the immune system), electrolytes 
and kidney function (disturbed if the kidney is 
involved), liver enzymes, and complete blood count.  
https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus#Diagnosis 
Systemic Lupus Erythematosus 
(Laboratory Tests) 3 
• The  lupus erythematosus  (LE) cells are only found 
in 50–75% of SLE cases, and they are also found in 
some people with rheumatoid arthritis, 
scleroderma, and drug sensitivities.  
https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus#Diagnosis 
Systemic Lupus Erythematosus 
(The American College of Rheumatology Revised 
Classification) 
http://www.eular.org/myuploaddata/files/sample%20chapter20_mod%2017.pdf 
Systemic Lupus Erythematosus 
(the European League Against Rheumatism (EULAR) 
released recommendations for the treatment of SLE) 
• In patients without major organ manifestations, 
glucocorticoids and antimalarial agents may be 
beneficial. 
• NSAIDs may be used for short periods in patients at 
low risk for complications from these drugs.  
• Consider immunosuppressive agents (e.g., 
azathioprine, mycophenolate mofetil, 
methotrexate) in refractory cases or when steroid 
doses cannot be reduced to levels for long-term 
use.   
http://emedicine.medscape.com/article/332244-overview#showall 
Systemic Lupus Erythematosus 
(Medications) 
• Biologic disease-modifying antirheumatic drugs 
(DMARDs): belimumab, rituximab, IV immune 
globulin. 
• Nonbiologic DMARDS: cyclophosphamide, 
methotrexate, azathioprine, mycophenolate, 
cyclosporine. 
• Nonsteroidal anti-inflammatory drugs (NSAIDS): 
e.g., ibuprofen, naproxen, diclofenac. 
• Corticosteroids: e.g., methylprednisolone, 
prednisone 
• Antimalarials: e.g., hydroxychloroquine. 
http://emedicine.medscape.com/article/332244-overview#showall 
Systemic Lupus Erythematosus 
(Adjunctive therapies) 
• No diet-based treatment has been proven effective.  
• Patients should be reminded that activity may need 
to be modified as tolerated.  
• Stress and physical illness may precipitate SLE 
flares.  
• Persons with SLE should wear sunscreen and 
protective clothing or avoid sun exposure to limit 
photosensitive rash or disease flares. 
• Vitamin D supplementation may improve 
endothelial function.  
http://emedicine.medscape.com/article/332244-overview#showall 
US MLE TEST 
A 29-year-old woman with a 3-year history of systemic lupus 
erythematosus (SLE) presents to her rheumatologist for 
routine follow up. Her course has been complicated by lupus 
nephritis (baseline creatinine 1.1 mg/dL) and she has been on 
stable doses of methotrexate and hydroxychloroquine for the 
last 2 months following a flare. Which of the following lab 
values can be used to best monitor this patient's disease? 
1.  Anti-nuclear antibody, 2.  Anti-dsDNA antibody, 3.  Anti-
Smith antibody, 4.  Anti-RNP antibody, 5.  CH50 level.  
https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 2.   In patients with SLE, the level of 
anti-dsDNA antibody can be used to monitor disease activity.  
Incorrect Answers: 
1: ANA is useful in the initial diagnosis of SLE but is not used 
to track disease progress, 3: Anti-Smith antibody is specific 
but not sensitive for SLE and, like anti-dsDNA, is particularly 
tied to lupus nephritis. However, it is not used to track the 
disease course, 4: Anti-RNP is not used to track a patient's SLE 
disease course, 5: Although CH50 levels can be reduced in 
lupus flares, it is much more common to track C3 and C4 
levels. 
https://www.mommd.com/usmle1to10.shtml 
Systemic Lupus Erythematosus 
(Multisystemic Approach) 
• Rheumatologist. 
• Infectious disease specialist. 
• Neurologist. 
• Pulmonologist. 
• Cardiologist. 
• Gastroenterologist. 
• Nephrologist. 
• Dermatologist. 
• Hematologist. 
• High-risk obstetrician. 
http://emedicine.medscape.com/article/332244-overview#showall 
Scleroderma    
(Definition) 1 
• Scleroderma (systemic sclerosis (SSc)) is a rare 
chronic disease of unknown cause characterized by 
diffuse fibrosis, degenerative changes, and vascular 
abnormalities in the skin, joints, and internal organs 
(especially the esophagus, lower GI tract, lungs, 
heart, and kidneys) .  
• Common symptoms include Raynaud phenomenon, 
polyarthralgia, dysphagia, heartburn, and swelling 
and eventually skin tightening and contractures of 
the fingers.   
http://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/autoimmune-rheumatic-disorders/systemic-sclerosis 
Scleroderma    
(Definition) 2 
•  Lung, heart, and kidney involvement accounts for 
most deaths.   
http://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/autoimmune-rheumatic-disorders/systemic-sclerosis 
Scleroderma    
(Manifestations) 1 
• Skin and nail manifestations (swelling of the skin, 
telangiectasias, sclerodactyly, masklike face, 
subcutaneous calcifications, digital ulcers). 
• Joint manifestations (polyarthritis, flexion 
contractures in the fingers, wrists, and elbows, etc.). 
• Gastrointestinal (GI)manifestations (dysphagia, 
malabsorption, pneumatosis intestinalis, peritonitis, 
and biliary cirrhosis).  
http://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/autoimmune-rheumatic-disorders/systemic-sclerosis 
Scleroderma    
(Manifestations) 2 
• Cardiopulmonary manifestations (lung fibrosis, 
leading to restrictive disease with eventual 
respiratory failure, pulmonary hypertension, heart 
failure, pericarditis, and heart arrhythmias). 
• Renal manifestations (severe renal disease, usually 
heralded by sudden, severe hypertension with 
features of thrombotic microangiopathic hemolytic 
anemia). 
http://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/autoimmune-rheumatic-disorders/systemic-sclerosis 
Scleroderma    
(Sclerodactyly) 
http://images.slideplayer.com/32/10064496/slides/slide_60.jpg 
Scleroderma    
(Masklike Face) 
http://www.ijdvl.com/articles/2013/79/3/images/ijdvl_2013_79_3_439_110801_f5.jpg 
Scleroderma    
(Subcutaneous Calcifications) 
http://www.pcds.org.uk/ee/images/made/ee/images/uploads/clinical/calcificacion06CREST_600_450_70_http:www.pcds.org.ukeeassetsimgwatermark.gif_0_0_80_r_b_-5_-5_.jpg 
Scleroderma    
(Digital Ulcers) 
http://what-when-how.com/wp-content/uploads/2012/04/tmpE87_thumb222.jpg 
Scleroderma    
(Flexion Contractures In The Fingers) 
https://handlab.com/resources/wp-content/uploads/2014/04/CP2-1.jpg 
Scleroderma    
(2013  ECR/EULAR Criteria) 
http://www.rheumtutor.com/2013-acreular-classification-criteria-for-scleroderma/ 
Scleroderma    
(Early Diagnosis - the VEDOSS Initiative) 
The VEDOSS (Very Early Diagnosis Of Systemic 
Sclerosis) initiative in Europe identified the following 
features as being key to diagnosing scleroderma in the 
very early stage: 
• Antinuclear antibodies. 
• Scleroderma-specific antibodies. 
• Scleroderma pattern on nailfold capillaroscopy. 
• Puffy fingers in Raynaud's syndrome patients. 
http://patient.info/doctor/systemic-sclerosis-scleroderma 
Scleroderma    
(Management) 1 
• There is no cure for scleroderma, and management 
consists of controlling symptoms and preventing 
complications. 
• Non-selective immunosuppressive 
cyclophosphamide has been associated with 
improvements in both pulmonary function and skin 
involvement but efficacy may reduce beyond two 
years.  
• Mycophenolate mofetil has also been used with 
improvements in lung function.   
https://en.wikipedia.org/wiki/Systemic_scleroderma http://patient.info/doctor/systemic-sclerosis-scleroderma 
Scleroderma    
(Management) 2 
• Azathioprine and methotrexate alone may not be as 
beneficial but have been shown to be effective for 
skin involvement. 
• T-cell targeted therapy which is being tested 
includes sirolimus, antithymocyte globulin, and 
basiliximab. 
• Oral corticosteroids.  
https://en.wikipedia.org/wiki/Systemic_scleroderma http://patient.info/doctor/systemic-sclerosis-scleroderma 
Scleroderma    
(Management) 3 
 
•  Nifedipine, nitroglycerin, phosphodiesterase type 5 
inhibitors, prostaglandins are the drugs for 
Raynaud's phenomenon. 
• In all other cases symptomatic treatment only. 
https://en.wikipedia.org/wiki/Systemic_scleroderma http://patient.info/doctor/systemic-sclerosis-scleroderma 
US MLE TEST 
A 39-year-old woman presents to clinic with multiple 
complaints. She has trouble swallowing both solids and 
liquids. She also reports that when she goes out in the cold, 
her fingers get extremely pale. Vital signs are stable. Physical 
exam reveals calcinosis of the digits and sclerodactyly as well 
as telangiectasia over the digits and at the nail bed. One 
would expect which of the following diagnostic tests to be 
positive?  
1.  Antihistone antibodies, 2.  Anticentromere antibodies  
3.  Antidesmoglein antibodies, 4.  Antimitochondrial 
antibodies, 5.  Anti-glomerular basement antibodies.  
https://www.mommd.com/usmle1to10.shtml 
US MLE TEST EXPLANATION 
The correct answer is 2. This patient has all of the findings in 
CREST syndrome – Calcinosis, Raynaud's, Esophageal 
dysmotility, Sclerodactyly, and Telangiectasias. 
Anticentromere antibodies are positive in CREST.  
Incorrect Answers: 
1: Antihistone antibodies are positive in drug-induced SLE, 3: 
Antidesmoglein antibodies may be positive in pemphigus 
vulgaris, 4: Antimitochondrial antibodies may be positive in 
primary biliary cirrhosis, 5: Anti-glomerular basement 
membrane antibodies may be positive in Goodpasture’s 
syndrome. 
https://www.mommd.com/usmle1to10.shtml 
Scleroderma    
(Patient Support Groups) 
• The Juvenile Scleroderma Network is an 
organization dedicated to provide emotional 
support and educational information to parents 
and their children living with juvenile scleroderma. 
• In the US, the Scleroderma Research Foundation is 
dedicated to raise awareness of the disease and 
assist those who are affected. 
• The Scleroderma Society is a UK charity founded in 
1982 to provide support for both people with 
scleroderma and their families. 
https://en.wikipedia.org/wiki/Systemic_scleroderma 
Sjögren syndrome    
(Definition) 
Sjögren syndrome (Sjögren's syndrome (SS)) is a 
systemic chronic autoimmune inflammatory disorder 
characterized by lymphocytic infiltrates in exocrine 
organs with sicca symptoms, such as xerophthalmia 
(dry eyes), xerostomia (dry mouth), and parotid gland 
enlargement.  
 
http://emedicine.medscape.com/article/332125-overview 
Sjögren syndrome     
(Glandular Manifestations) 1 
• Sjögren syndrome typically presents as dry eyes 
and dry mouth, also referred to as xerophthalmia 
(or keratoconjunctivitis sicca) and xerostomia, 
respectively. 
• Eye symptoms include dryness, grittiness, pruritus, 
and foreign body sensation.  
• Oral symptoms include difficulty speaking, eating, 
or swallowing, and frequent sips of water may be 
needed.  
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Glandular Manifestations) 2 
• The patient’s eye may show conjunctival injection . 
• Early oral findings include decreased salivary pool 
and dry mucous membranes, which can progress to 
erythema, fissuring, and ulceration. 
• The patient may also have multiple dental caries as 
a result of decreased salivary flow. 
• Parotid glands may be tender or swollen.   
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Extraglandular Manifestations) 1 
• Arthralgia or nonerosive arthritis characterized by 
tenderness, swelling, or effusion of peripheral 
joints. 
• Gastrointestinal symptoms (reflux, dyspepsia, 
diarrhea, constipation). 
• Autoimmune thyroiditis. 
• Pulmonary disease (chronic cough, recurrent 
bronchitis with chronic diffuse interstitial infiltrates 
on radiography, abnormal spirometry, pulmonary 
alveolitis or fibrosis on computed tomography).  
 
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Extraglandular Manifestations) 2 
• Raynaud’s phenomenon. 
• Cutaneous vasculitis. 
• Peripheral neuropathy. 
• Lymphadenopathy (enlarged lymph nodes in 
cervical, axillary, or inguinal region). 
• Renal involvement (proteinuria, renal tubular 
acidosis, interstitial nephritis, glomerulonephritis, 
abnormal urinalysis). 
• Fever not associated with infectious process. 
 http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Dry Eyes) 
http://www.rheum-care.com/wp-content/uploads/2014/05/stock-photo-16982142-blood-capillary-human-eye.jpg 
Sjögren syndrome     
(Dry Mouth) 
http://1.bp.blogspot.com/_PUjYKIyEP6g/TLvbsvFVfYI/AAAAAAAADTI/WZ0pX1oMZys/s640/nyc-dentist-blog-dry-mouth.jpg 
Sjögren syndrome     
(Arthritis ) 
http://www.healthline.com/hlcmsresource/images/slideshow/secondary-sjogrens-syndrome-and-arthritis/285x285_Secondary_Sjogrens_Syndrome_And_Arthritis_Doctor_9.jpg 
Sjögren syndrome     
(Pulmonary Fibrosis) 
http://www.radiologyassistant.nl/data/bin/w440/a5097977c62e89_sarc-fibrosis.jpg 
Sjögren syndrome     
(Raynaud’s Phenomenon) 
http://userfiles.steadyhealth.com/userfiles/articles/thumb_raynaud-syndrome.jpg 
Sjögren syndrome     
(Lymphadenopathy) 
http://www.antimicrobe.org/images-Monographs/e27_TB_1.jpg 
Sjögren syndrome     
(Diagnostic Testing: Eye Symptoms ) 1 
• Eye symptoms are usually evaluated with the 
Schirmer test or the rose bengal test.  
• The Schirmer test involves placing a sterile filter 
paper strip beneath the lower eyelid for five 
minutes. If the moistened area measures less than 
5 mm, the test is positive.   
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Diagnostic Testing: Eye Symptoms ) 2 
• The rose bengal test usually is performed by an 
ophthalmologist; 1% rose bengal dye is instilled 
and the ocular surface integrity is evaluated by 
quantitatively scoring the staining of the 
conjunctiva.  Rose bengal dye will stain devitalized 
corneal and conjunctival epithelial cells. The test 
will identify keratosclerosis (KCS) when minimal 
ocular symptoms are present. A routine slit-lamp 
evaluation can identify a diminished tear meniscus.  
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Diagnostic Testing: Oral Dryness) 
• Oral dryness can be evaluated objectively by 
nonstimulated whole saliva flow collection, in which 
the patient spits into a graduated test tube every 
minute for 15 minutes.  Collection of less than 1.5 
mL in 15 minutes is considered a positive result.  
• Other tests include contrast sialography, which 
visualizes the salivary glands and ducts via contrast 
dye injection into the Stensen duct, and 
scintigraphy, which evaluates salivary gland function 
by measuring sequential uptake and excretion of 
technetium 99m.  http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(Diagnostic Testing: Biopsy) 
• Although once considered the gold standard for 
diagnosis of Sjögren syndrome, minor salivary gland 
biopsy of tissue taken from the patient’s lip is not 
always necessary. 
• A positive biopsy is defined as at least one focus of 
dense, inflammatory infiltrate containing at least 50 
lymphocytes per 4 mm2. 
• The lip biopsy may be useful in ambiguous cases or 
when therapy beyond symptom management is 
being considered. 
http://www.aafp.org/afp/2009/0315/p465.html 
Sjögren syndrome     
(American-European Consensus Sjögren Classification 
Criteria: 1) 
 I. Ocular Symptoms (at least one) 
Dry eyes >3 months? 
Foreign body sensation in the eyes? 
Use of artificial tears >3x per day? 
II. Oral Symptoms (at least one) 
Dry mouth >3 months? 
Recurrent or persistently swollen salivary 
glands? 
Need liquids to swallow dry foods? 
III. Ocular Signs (at least one) 
Schirmer's test, (without anesthesia) ≤5 
mm/5 minutes 
Positive vital dye staining (van Bijsterveld 
≥4) 
https://www.sjogrens.org/home/research-programs/healthcare-providers/diagnosis-criteria 
IV. Histopathology Lip biopsy 
showing focal lymphocytic 
sialoadenitis 
     (focus score ≥1 per 4 mm2)2 
 
V. Oral Signs (at least one) 
Unstimulated whole salivary 
flow (≤1.5 mL in 15 minutes) 
Abnormal parotid sialography3 
Abnormal salivary scintigraphy4 
 
VI. Autoantibodies (at least one) 
Anti-SSA (Ro) or Anti-SSB (La) 
Sjögren syndrome     
(American-European Consensus Sjögren 
Classification Criteria: 2) 
For a primary Sjögren diagnosis 
a. Any 4 of the 6 criteria, must 
include either item IV 
(Histopathology) or VI 
(Autoantibodies) 
b. Any 3 of the 4 objective 
criteria (III, IV, V, VI) 
For a secondary Sjögren diagnosis 
https://www.sjogrens.org/home/research-programs/healthcare-providers/diagnosis-criteria 
In patients with another well-
defined major connective 
tissue disease, the presence of 
one symptom (I or II) plus 2 of 
the 3 objective criteria (III, IV 
and V) is indicative of 
secondary SS. 
Exclusion Criteria 
Past head and neck radiation treatment, Hepatitis C infection, Acquired 
immunodeficiency syndrome (AIDS), Pre-existing lymphoma, Sarcoidosis, Graft versus 
host disease, Current use of anticholinergic drugs 
Sjögren syndrome     
(Patient education) 
Educate patients with Sjögren syndrome on 
avoidance strategies and self-care issues for the 
treatment of dry mouth, eyes, skin, and vagina.  
http://emedicine.medscape.com/article/332125-overview 
Sjögren syndrome     
(Treatment) 
• Neither a cure nor a specific treatment is known to 
permanently restore gland secretion. Instead, treatment is 
generally symptomatic and supportive. 
• Eye care: moisture replacement (artificial tears), goggles, 
cyclosporine, cevimeline, and pilocarpine.  
• Vaginal dryness: personal lubricants. 
• Musculoskeletal: nonsteroidal anti-inflammatory 
drugs (NSAIDs), corticosteroids, intravenous 
immunoglobulin), disease-modifying antirheumatic 
drugs (DMARDs). 
• Systemic: biologic disease-modifying antirheumatic 
drugs (DMARDs).  https://en.wikipedia.org/wiki/Sj%C3%B6gren%27s_syndrome#Treatment 
Sjögren syndrome     
(Surgical Therapy) 
• Occlusion of the lacrimal puncta can be corrected 
surgically; electrocautery and other techniques can 
be used for permanent punctal occlusion. 
• During surgery, the anesthesiologist should 
administer as little anticholinergic medication as 
possible and use humidified oxygen to help avoid 
inspissation of pulmonary secretions.  
• Good postoperative respiratory therapy should also 
be provided; patients are at higher risk for corneal 
abrasions, so ocular lubricants should be 
considered. http://emedicine.medscape.com/article/332125-treatment#showall 
Mixed Connective Tissue Disease    
(Definition) 
Mixed connective tissue disease (MTCD), 
or  undifferentiated connective tissue disease  is a 
rare chronic autoimmune inflammatory connective 
tissue disorder characterized by the presence of high 
titers of a distinctive autoantibody anti-U1 
ribonucleoprotein (RNP) what may be an overlapping 
group of connective tissue disorders (e.g., systemic 
lupus erythematosus, polymyositis, and scleroderma) 
that cannot be diagnosed in more specific terms.   
http://rarediseases.org/rare-diseases/mixed-connective-tissue-disease-mctd/ 
Mixed Connective Tissue Disease    
(Manifestation) 
• MCTD combines features of scleroderma, myositis, 
systemic lupus erythematosus, rheumatoid 
arthritis, dermatomyositis, Raynaud’s 
phenomenon,  etc. and is thus considered 
an overlap syndrome. 
• Patients who have MCTD have symptoms similar to 
those of patients with other connective tissue 
disorders, including fatigue, muscle pain with no 
apparent cause, joint fever, Raynaud phenomenon, 
severe polymyositis, intense arthritis, etc. 
 http://my.clevelandclinic.org/health/diseases_conditions/hic_Mixed_Connective_Tissue_Disease 
Mixed Connective Tissue Disease    
(The "classic" symptoms) 
• Raynaud phenomenon. 
• Swollen "sausage-like" fingers, sometimes 
temporary but at other times progressing into 
sclerodactyly (thin fingers with hardened skin and 
limited movement). 
• Inflamed joints and muscles. 
• Pulmonary hypertension (high blood pressure in 
the blood vessels of the lungs). 
http://my.clevelandclinic.org/health/diseases_conditions/hic_Mixed_Connective_Tissue_Disease 
Mixed Connective Tissue Disease    
(Raynaud Phenomenon) 
http://www.physio-pedia.com/images/3/34/Ray.png 
Mixed Connective Tissue Disease    
(Swollen “Sausage-Like" Fingers) 
http://www.physio-pedia.com/images/7/70/PsAHands.jpg 
Mixed Connective Tissue Disease    
(Inflamed Joints and Muscles) 
http://images.medicinenet.com/images/rheumatoid-arthritis-feet.jpg 
Mixed Connective Tissue Disease    
(Pulmonary hypertension) 
http://www.scielo.br/img/revistas/rb/v41n3/en_12f8.gif 
Mixed Connective Tissue Disease    
(Alarcon-Segovia Diagnostic Criteria) 1 
• Serological criteria: Positive anti U1 RNP at 
hemagglutination titer >1:1600 
• 2. Clinical criteria: 
• Oedema of hands 
• Synovitis 
• Myositis 
• Raynaud´s 
• Acrosclerosis  
http://www.medicalcriteria.com/criteria/reu_mctd.htm 
Mixed Connective Tissue Disease    
(Alarcon-Segovia Diagnostic Criteria) 2 
• Serological criteria: Positive anti U1 RNP at 
hemagglutination titer >1:1600 
• 2. Clinical criteria: 
• Oedema of hands 
• Synovitis 
• Myositis 
• Raynaud´s 
• Acrosclerosis  
http://www.medicalcriteria.com/criteria/reu_mctd.htm 
Mixed Connective Tissue Disease    
(Standard Therapies) 1 
• The treatment is based upon the specific symptoms 
present in each case.  
• Many of the manifestations of MCTD appear to 
respond to therapy with corticosteroids such as 
prednisone.  
• Mild forms appear to be controlled by nonsteroidal 
anti-inflammatory drugs (NSAIDs) or low doses of 
corticosteroids. When more severe involvement of 
major organs occurs, larger doses of corticosteroids 
may be of benefit.    
 http://www.medicalcriteria.com/criteria/reu_mctd.htm 
Mixed Connective Tissue Disease    
(Standard Therapies) 2 
• In some cases, drugs that suppress the immune 
system (e.g. disease-modifying antirheumatic drugs) 
have been used to treat individuals with MCTD. 
• Calcium channel blockers may be used to treat 
Raynaud's phenomenon. 
• Bosentan or sildenafil may be used to treat 
Pulmonary hypertension.  
 
http://www.medicalcriteria.com/criteria/reu_mctd.htm 
Prognosis 1  
• The prognosis for patients who have SCTD is 
different for different diseases and varies from a 
benign course to severe progressive course. 
• There are many possible outcomes, depending on 
the organs affected, the degree of inflammation, 
and how quickly the disease progresses.  
• In approximately one third of patients the clinical 
symptoms go into long-term remission. 
• One third of patients have a severe, progressive 
SCTD course.   
http://www.ncbi.nlm.nih.gov/pubmed/16084324 
Prognosis 2 
•   
• Persistent morbidity often is attributable to 
arthritis, easy fatiguability, and dyspnea on 
exertion.  
• Most deaths from SCTD are due to heart failure 
caused by pulmonary arterial hypertension (PAH). 
http://www.ncbi.nlm.nih.gov/pubmed/16084324 
Prophylaxis 
• Since the causes of SCTD are not known, there is no 
way of preventing these diseases, however, lifestyle 
and environmental factors if modified could assist in 
it.   
• Progression some forms of SCTD could be 
prevented if treated aggressively prior to 
manifestations of symptoms, however, if such is the 
case, criteria would have to be determined for 
patient selection for this preventive treatment, and 
only those patients whose probability to develop 
clinical disease exceeds the established threshold, 
should be treated while asymptomatic. 
http://www.arc.org.uk/arthinfo/medpubs/6529/6529.asp 
Abbreviations  
ACE – angiotensin converting 
enzyme  
AIDS - Acquired immunodeficiency  
ANA  - antinuclear antibody  
syndrome  
anti-ENA - anti-extractable nuclear 
antigen 
ARBs - angiotensin II receptor 
antagonists  
CPK - creatine phosphokinase  
DIP - distal interphalangeal joints 
DMARDs - disease-modifying 
antirheumatic drugs  
dsDNA - anti-double stranded DNA 
antibodies  
EMG - myophatic electromyogram  
EULAR - European League Against 
Rheumatism  
 
KCS - keratosclerosis 
LE - lupus erythematosus   
MCP - metacarpophalangeal joints 
MCTD - Mixed Connective Tissue Disease  
MFS - Marfan syndrome 
NSAIDS - nonsteroidal anti-inflammatory 
drugs  
PAH - pulmonary arterial hypertension 
PIP - proximal interphalangeal joints 
RNP - anti-U1 ribonucleoprotein  
SCTD - systemic connective tissue diseases 
SS - Sjögren's syndrome  
SSc - systemic sclerosis  
VEDOSS - Very Early Diagnosis Of GI - 
gastrointestinal  
Diagnostic and treatment guidelines 
Marfan Syndrome 
Medical Management of Marfan Syndrome 
MARFAN DX: A Diagnostic Tool for Healthcare Professionals 
Systemic Lupus Erythematosus (SLE) Treatment & Management 
Systemic Lupus Erythematosus: Pathogenesis 20 and Clinical 
Features  
Guidelines for clinical trials in systemic sclerosis (scleroderma) 
Systemic Sclerosis 
Diagnosis and Management of Sjögren Syndrome 
Sjogren Syndrome Treatment & Management 
Mixed Connective Tissue Disease 
 
 
